Danone reports sales of US$7.9B in Q1 2026

FRANCE – Danone has reported that sales stood at US$7.85 billion (€6.7 billion), up +2.7% LFL, led by an increase of +1.5% in volume/mix and +1.2% in price in Q1 2026.

On a reported basis, sales decreased by -2.0%, negatively impacted by forex (-5.6%). This mainly reflects the depreciation of several currencies against the euro, notably the US dollar, the Argentine peso, the Indonesian rupiah and the Chinese renminbi.

In addition, scope (+0.5%) and contribution from hyperinflation (+0.3%) both had a positive impact on reported sales.

EMEA LFL sales increased by +0.6%, with volume/mix at -1.4% and price at +2.0%. Within the region, Europe delivered LFL sales growth of +0.4%, with volume/mix at –1.1% and price at +1.5%.

EDP delivered sustained momentum across the region, driven by Danone, Activia, Alpro and High Protein. Specialized Nutrition was impacted by the IMF recall in Europe and the conflict in the Middle East, while evian drove robust growth in Waters.

In the Americas, LFL sales were up +3.4%, with volume/mix at +2.5% and price at +0.9%. Within the region, North America delivered LFL sales growth of +1.5%, with volume/mix at +1.7% and price at -0.3%.

EDP growth was supported by continued strength in High Protein across the region. In the U.S., STōK continued to perform strongly while Coffee creamers are progressively improving.

Specialized Nutrition delivered strong growth, driven by Aptamil in Latin America and Neocate in North America. Waters posted a solid quarter.

Antoine de Saint-Affrique CEO at Danone stated, “This first quarter demonstrated again the resilience, strength and relevance of our health focused portfolio: against a challenging backdrop, we delivered a solid performance of +2.7% LFL, driven by positive volume/mix across all categories.

“Our winning platforms continued to perform strongly, notably in dairy with high protein, skyr and kefir, in Waters with evian and Mizone, as well as in medical nutrition around the globe. We accelerated our transformation with the signing of two transactions that will further strengthen our portfolio: the acquisition of Huel, and the creation of a dairy joint venture with Arcor.”

In Asia Pacific, LFL sales rose by +6.0%, with volume/mix at +6.2% and price at -0.1%. Within the region, China, North Asia & Oceania (CNAO) posted LFL sales growth of +10.3% with volume/mix at +10.5% and price at -0.2%.

EDP maintained strong momentum in Japan. In Specialized Nutrition, CNAO delivered a solid performance in both IMF and Medical Nutrition. In Waters, Mizone posted solid growth while Indonesia was impacted by floods.

To receive our email newsletters with the latest news and insights from Africa, the Middle East and around the world, SUBSCRIBE HERE